» Articles » PMID: 14680412

Overview of Partial Compliance

Overview
Specialty Psychiatry
Date 2003 Dec 19
PMID 14680412
Citations 30
Authors
Affiliations
Soon will be listed here.
Abstract

A substantial proportion of patients with psychiatric and nonpsychiatric chronic illnesses fail to take their medications as prescribed. A number of studies suggest that 50% or more of individuals with schizophrenia are noncompliant with medications at some time during their illness. In most cases, patients are partially compliant, taking only a portion of their prescribed medications. Noncompliance is probably the most important element contributing to relapse in schizophrenia. Factors contributing to the rate of noncompliance include medication side effects, the severity of psychotic symptoms, impaired cognition, and an inadequate understanding of the role of medication for preventing relapse. In addition, both patients and clinicians overestimate patients' compliance. Strategies for managing partial compliance include the treatment of medication side effects, the education of patients about their illness, and the use of long-acting antipsychotic formulations.

Citing Articles

Comparative Effectiveness of Second Generation Long-acting Injectable Antipsychotics Based on Nationwide Database Research in Hungary: An Update.

Takacs P, Kunovszki P, Timtschenko V, Feher L, Balazs T, Hegyi R Schizophr Bull Open. 2024; 3(1):sgac013.

PMID: 39144770 PMC: 11205877. DOI: 10.1093/schizbullopen/sgac013.


Family psychoeducation in schizophrenia and schizophrenia related disorder, treatment compliance, and suicidal risk reduction: questions about their relationship from a naturalistic observation.

Hode Y, Padovani R, Hikmat W, Guillard-Bouhet N, Attal J, Bralet M Front Psychiatry. 2024; 15:1370566.

PMID: 38638418 PMC: 11024790. DOI: 10.3389/fpsyt.2024.1370566.


Effectiveness of Paliperidone Palmitate in Reducing Acute Psychiatric Service Use for Patients Suffering from Psychosis-A Retrospective Mirror-Image Study.

Chan C, Verma S, Subramaniam M, Abdin E, Tay J Int J Environ Res Public Health. 2023; 20(4).

PMID: 36834095 PMC: 9961511. DOI: 10.3390/ijerph20043403.


Weekly Supervised Administration of Oral Antipsychotics: An Alternative to Long-Acting Injections?.

Brissos S, Taylor D CNS Drugs. 2022; 36(4):315-325.

PMID: 35226350 DOI: 10.1007/s40263-022-00906-4.


Assessing Outcomes Between Risperidone Microspheres and Paliperidone Palmitate Long-Acting Injectable Antipsychotics Among Veterans.

Ibrahim H, Malcolm B, Gogineni H Fed Pract. 2022; 38(12):586-591.

PMID: 35177888 PMC: 8843007. DOI: 10.12788/fp.0195.